Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Neuropeptide S ELISA Kit (AC3939)
Cat.#: ASET-2528
Specifications
Description Human Neuropeptide S ELISA Kit allows for the in vitro quantitative determination of human Neuropeptide S concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2429 Human PPAR gamma ELISA Kit (AC3840) Quantitative inquiry ASET-1956 Mouse NOTCH3 ELISA Kit (AC3367) Quantitative inquiry ASET-1768 Human PAX8 ELISA Kit (AC3179) Quantitative inquiry ASET-1651 Vasopressin ELISA Kit (AC3062) Quantitative inquiry ASET-1601 Human CBLN1 ELISA Kit (AC3012) Quantitative inquiry ASET-2136 Human 5HT2A Receptor ELISA Kit (AC3547) Quantitative inquiry ASET-1572 Human Adenosine A1 Receptor ELISA Kit (AC2983) Quantitative inquiry ASET-1499 Human Neuroligin 1 ELISA Kit (AC2910) Quantitative inquiry ASET-1577 Mouse Noradrenaline Transporter ELISA Kit (AC2988) Quantitative inquiry ASET-1628 Human HAS3 ELISA Kit (AC3039) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket